ARTICLE | Clinical News
PV-10 regulatory update
May 2, 2011 7:00 AM UTC
FDA granted Orphan Drug designation for Provectus' PV-10 to treat hepatocellular carcinoma (HCC). The sterile injection containing 10% rose bengal disodium is in Phase I testing for HCC and has comple...